GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 33 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $51,000 | -3.8% | 23,450 | 0.0% | 0.00% | – |
Q4 2020 | $53,000 | -15.9% | 23,450 | 0.0% | 0.00% | – |
Q3 2020 | $63,000 | -12.5% | 23,450 | 0.0% | 0.00% | – |
Q2 2020 | $72,000 | +56.5% | 23,450 | 0.0% | 0.00% | – |
Q1 2020 | $46,000 | -31.3% | 23,450 | 0.0% | 0.00% | – |
Q4 2019 | $67,000 | -22.1% | 23,450 | 0.0% | 0.00% | – |
Q3 2019 | $86,000 | -11.3% | 23,450 | 0.0% | 0.00% | – |
Q2 2019 | $97,000 | -19.2% | 23,450 | 0.0% | 0.00% | – |
Q1 2019 | $120,000 | +50.0% | 23,450 | 0.0% | 0.00% | – |
Q4 2018 | $80,000 | -43.3% | 23,450 | 0.0% | 0.00% | – |
Q3 2018 | $141,000 | -5.4% | 23,450 | 0.0% | 0.00% | – |
Q2 2018 | $149,000 | +34.2% | 23,450 | 0.0% | 0.00% | – |
Q1 2018 | $111,000 | +42.3% | 23,450 | 0.0% | 0.00% | – |
Q4 2017 | $78,000 | +56.0% | 23,450 | 0.0% | 0.00% | – |
Q3 2017 | $50,000 | -13.8% | 23,450 | 0.0% | 0.00% | – |
Q2 2017 | $58,000 | +7.4% | 23,450 | 0.0% | 0.00% | – |
Q1 2017 | $54,000 | +134.8% | 23,450 | 0.0% | 0.00% | – |
Q4 2016 | $23,000 | -14.8% | 23,450 | 0.0% | 0.00% | – |
Q3 2016 | $27,000 | -22.9% | 23,450 | 0.0% | 0.00% | – |
Q2 2016 | $35,000 | +2.9% | 23,450 | 0.0% | 0.00% | – |
Q1 2016 | $34,000 | -10.5% | 23,450 | 0.0% | 0.00% | – |
Q4 2015 | $38,000 | -30.9% | 23,450 | 0.0% | 0.00% | – |
Q3 2015 | $55,000 | -14.1% | 23,450 | 0.0% | 0.00% | – |
Q2 2015 | $64,000 | -23.8% | 23,450 | 0.0% | 0.00% | – |
Q1 2015 | $84,000 | 0.0% | 23,450 | 0.0% | 0.00% | – |
Q4 2014 | $84,000 | -28.8% | 23,450 | 0.0% | 0.00% | – |
Q3 2014 | $118,000 | -63.6% | 23,450 | 0.0% | 0.00% | – |
Q2 2014 | $324,000 | +14.9% | 23,450 | 0.0% | 0.00% | – |
Q1 2014 | $282,000 | +48.4% | 23,450 | 0.0% | 0.00% | – |
Q4 2013 | $190,000 | -18.8% | 23,450 | 0.0% | 0.00% | – |
Q3 2013 | $234,000 | +134.0% | 23,450 | 0.0% | 0.00% | – |
Q2 2013 | $100,000 | – | 23,450 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cutter & CO Brokerage, Inc. | 184,742 | $401,000 | 0.10% |
Geneos Wealth Management Inc. | 511,606 | $2,261,000 | 0.06% |
SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $26,000 | 0.01% |
OCCUDO QUANTITATIVE STRATEGIES LP | 18,967 | $41,000 | 0.01% |
Vivaldi Capital Management LP | 10,668 | $45,000 | 0.01% |
OSAIC HOLDINGS, INC. | 1,221,984 | $2,651,000 | 0.01% |
CENTAURUS FINANCIAL, INC. | 15,614 | $34,000 | 0.00% |
WEDBUSH SECURITIES INC | 17,998 | $39,000 | 0.00% |
D.A. DAVIDSON & CO. | 65,310 | $142,000 | 0.00% |
Virtu Financial LLC | 14,683 | $32,000 | 0.00% |